Epidemiology of prostate cancer in Asian countries

International Journal of Urology - Tập 25 Số 6 - Trang 524-531 - 2018
Takahiro Kimura1, Shin Egawa1
1Department of Urology, Jikei University School of Medicine, Tokyo, Japan

Tóm tắt

Abstract

The incidence of prostate cancer has been increasing worldwide in recent years. The GLOBOCAN project showed that prostate cancer was the second most frequently diagnosed cancer and the fifth leading cause of cancer mortality among men worldwide in 2012. This trend has been growing even in Asian countries, where the incidence had previously been low. However, the accuracy of data about incidence and mortality as a result of prostate cancer in some Asian countries is limited. The cause of this increasing trend is multifactorial. One possible explanation is changes in lifestyles due to more Westernized diets. The incidence is also statistically biased by the wide implementation of early detection systems and the accuracy of national cancer registration systems, which are still immature in most Asian countries. Mortality rate decreases in Australia, New Zealand and Japan since the 1990s are possibly due to the improvements in treatment and/or early detection efforts employed. However, this rate is increasing in the majority of other Asian countries. Studies of latent and incidental prostate cancer provide less biased information. The prevalence of latent and incidental prostate cancer in contemporary Japan and Korea is similar to those in Western countries, suggesting the influence of lifestyle changes on carcinogenesis. Many studies reported evidence of both congenital and acquired risk factors for carcinogenesis of prostate cancer. Recent changes in the acquired risk factors might be associated with the increasing occurrence of prostate cancer in Asian countries. This trend could continue, especially in developing Asian countries.

Từ khóa


Tài liệu tham khảo

10.1111/iju.13441

10.1016/j.eururo.2012.02.054

10.1111/iju.13380

10.1038/nrurol.2014.42

10.1016/j.juro.2015.11.068

10.2741/1891

GLOBOCAN 2012: Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2012. Available from URL:http://globocan.iarc.fr/Default.aspx

10.3322/caac.21262

10.1620/tjem.72.91

10.1007/978-3-642-85849-9

10.1002/ijc.29210

10.4178/epih.e2017006

10.12954/PI.12014

Cancer Statistics in Japan. Available from URL:http://ganjoho.jp/reg_stat/statistics/dl/index.html

Singapore Cancer Registry Annual Registry Report 2015. Available from URL:https://www.nrdo.gov.sg/publications/cancer

10.1016/j.prnil.2015.06.003

10.7314/APJCP.2014.15.21.9125

10.1093/jjco/hyv066

10.7314/APJCP.2013.14.6.3581

10.3322/caac.21338

Ten‐Year Cancer Incidence Among Nationals of the GGC States 1998‐2007. Available from URL:https://www.moh.gov.bh/Content/Files/Publications/GCC%20Cancer%20Incidence%202011.pdf

National Cancer Control Programme MoHIM Public Health Complex Sri Lanka. Cancer Incidence Data Sri Lanka 2010. National Cancer Control Programme Ministry of Health & Indigenous Medicine Public Health Complex Sri Lanka. Available from URL:http://www.nccp.health.gov.lk/index.php/publications/cancer-registries

Bhurgri Y, 2009, Incidence and trends of prostate cancer in Karachi South, 1995–2002, Asian Pac. J. Cancer Prev., 10, 45

10.4103/0970-1591.174774

10.7314/APJCP.2014.15.22.9747

The Malaysian National Cancer Registry Report (MNCR) 2007–2011. Available from URL:https://kpkesihatan.com/2016/12/07/the-malaysian-national-cancer-registry-report-mncr-2007-2011/

Al Awadhi MA, 2016, Cancer incidence and mortality in the Kingdom of Bahrain statistics and trends, Bahrain Med. Bullet., 38, 30, 10.12816/0047384

WHO mortality data and statistics. Available from URL:http://apps.who.int/healthinfo/statistics/mortality/whodpms/

OB Ahmad C Boschi‐Pinto AD Lopez CJL Murray R Lozano M Inoue 2001 World Health Organization Geneva

10.1111/j.1442-2042.2009.02293.x

10.1002/ijc.2910290602

10.1620/tjem.74.265

10.1093/jnci/80.9.683

Stemmermann GN, 1992, A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience, Cancer Epidemiol. Biomarkers Prev., 1, 189

10.1093/jnci/50.5.1137

Lee YS, 1972, Latent prostate carcinoma in Singapore Chinese, Singapore Med. J., 13, 1

10.5980/jpnjurol1989.83.315

Zare‐Mirzaie A, 2012, The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience, Med J. Islam Repub. Iran, 26, 73

10.1007/s11255-009-9578-1

Yang CR, 1999, Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy, Mol. Urol., 3, 33

10.1016/S0929-6646(09)60085-1

10.1111/j.1745-7262.2006.00129.x

10.1111/j.1349-7006.2009.01267.x

10.1016/j.urology.2007.07.015

10.1111/j.1745-7262.2008.00420.x

10.1038/aja.2008.15

10.1590/S1677-55382007000200006

10.1016/j.urology.2008.02.040

10.1016/S0022-5347(01)62086-X

10.7314/APJCP.2015.16.13.5137

10.4103/1008-682X.132780

Pourmand G, 2007, The risk factors of prostate cancer: a multicentric case‐control study in Iran, Asian Pac. J. Cancer Prev., 8, 422

Life expectancy at birth total (years). The World Bank. Available from URL:https://data.worldbank.org

10.1002/cncr.22685

10.1038/ng823

10.1126/science.274.5291.1371

10.1038/84808

10.1038/ng994

10.1056/NEJMoa1110000

10.1002/pros.22552

10.1371/journal.pone.0164233

10.1038/nrc2402

10.1038/modpathol.2010.149

10.1002/pros.21265

10.1111/j.1440-1827.2011.02675.x

10.1111/pin.12006

10.1016/j.urology.2010.06.010

10.1158/0008-5472.CAN-09-4074

10.1016/j.cell.2008.04.013

10.1007/s100380050078

Dong JT, 2001, Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients, Clin. Cancer Res., 7, 304

10.1002/(SICI)1097-0045(19970101)30:1<53::AID-PROS8>3.0.CO;2-M

10.1002/gcc.21984

The International HapMap Project, 2003, Nature, 426, 789, 10.1038/nature02168

10.1038/nature04226

10.4155/fso.15.87

10.1158/2159-8290.CD-15-0315

Ross RK, 1987, Case‐control studies of prostate cancer in blacks and whites in southern California, J. Natl Cancer Inst., 78, 869

10.1038/bjc.1991.210

10.1097/01.ju.0000107838.33623.19

10.1093/jnci/87.9.652

Vlajinac H, 2010, Nutrition and prostate cancer, J. BUON, 15, 698

10.1080/01635581.2011.582224

10.1038/pcan.2016.39

10.1016/S0140-6736(00)04889-3

10.1136/bmj.g2272

10.1002/ijc.20030

EAU ‐ ESTRO ‐ SIOG Guidelines on Prostate Cancer. Available from URL:http://uroweb.org/guideline/prostate-cancer/

10.1093/annonc/mdr603

10.1111/iju.12023

Mori M, 2011, Weight gain and family history of prostate or breast cancers as risk factors for prostate cancer: results of a case‐control study in Japan, Asian Pac. J. Cancer Prev., 12, 743

Walsh PC, 2003, Germline mutations and sequence variants of macrophage scavenger receptor 1 gene are associated with prostate cancer risk, J. Urol., 169, 1589

10.1677/ERC-09-0087

10.1158/1055-9965.EPI-06-0410

10.1038/pcan.2012.40

10.1002/ijc.28989

10.1016/j.urolonc.2012.07.008

10.7314/APJCP.2012.13.8.4097

Thông tin
Thông tin xuất bản

International Journal of Urology

Tập 25 Số 6

524-531

Thông tin tác giả